Tilderin | Treatment for lameness in horses by CEVA

Teldrin is the ideal advanced option for treating equine lameness associated with skeletal and joint changes that affect horse performance, especially sport and racehorses.

This product was specifically developed to treat pathological changes in the bones of the scaphoid bone and scaphoid syndrome , also known as podotroclelar syndrome, navicular disease, or digital headache.

What are the benefits of Tilderin?

Treatment for equine lameness resulting from bone and cartilage disorders helps reduce pain and inflammation in the joints and supporting bones, promotes horse comfort, and restores its ability to move steadily and perform optimally in cases of osteochondrosis and chronic or recent scaphoid syndrome.

Dosage and method of use

• The freeze-dried powder is diluted using the diluent provided with the package in a sterile manner.
• It is given intravenously at a rate of 0.1 mg of telodronic acid per kg of body weight daily for 10 consecutive days.
• The typical dose is 1 ml of solution per 50 kg of horse weight per day.
• The solution is given via slow intravenous injection over at least 30 minutes, preferably using the jugular vein.

This medication targets the root cause of the problem and helps restore the horse's normal performance thanks to its effective formula containing telodronic acid. Order now.